Efficacy and safety of percutaneous CT three-dimensional reconstruction combined with ultrasound-guided radiofrequency ablation of thoracic sympathetic nerve in the treatment of primary handhidrosis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300073903

Enrollment

Unknown

Registered

2023-07-25

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary palmar hyperhidrosis

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) Patients with severe primary handhidrosis who were admitted to the Pain Department of the Third Xiangya Hospital of Central South University to receive radiofrequency thoracic sympathetic nerve ablation; 2) Patients who are willing to and actively cooperate with the trial.

Exclusion criteria

Exclusion criteria: 1) Preoperative head MRI showed intracranial lesions, related brain tumors or vascular malformations; 2) Patients with severe cardiopulmonary diseases who cannot receive general anesthesia; 3) Patients with severe coagulopathy; 4) Patients with puncture site infection; 5) Patients with preoperative pneumothorax and pleural effusion.

Design outcomes

Primary

Measure	Time frame
HDSS;(DLQI); QOL;Occurrence of pneumothorax;Patient satisfaction with efficacy;	—

Countries

China

Contacts

Public ContactHuang Dong

Third Xiangya Hospital of Central South University

huangdong@csu.edu.cn+86 137 8741 2741

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026